Latest filing published 25 Feb 2025 for China NT Pharma Group Co. Ltd., €10.7M.
Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chin Yu appears in our data through filings on China NT Pharma Group Co. Ltd. shares, published by HKEX. The record holds 18 filings, for trades running from 22 August 2017 to 21 February 2025.
Both buying and selling appear: 15 purchases worth €10.9M, against 3 sales worth €9.5M. The totals do not cover 4 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €9,639. On 13 out of 13 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 13 purchases show a median change of -38.4%, with the price up in 15% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 25 February 2025, the filings show an open-market purchase worth €10.7M in China NT Pharma Group Co. Ltd. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations